CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Intravitreal Antibiotics +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000130
NCT00000130Phase 3Completed
CompareCT.gov

Endophthalmitis Vitrectomy Study (EVS)

National Eye Institute (NEI)·interventional·Posted Sep 24, 1999·Updated Sep 17, 2009

In Brief

A Phase 3 clinical trial evaluating Intravitreal Antibiotics and Initial Pars Plana Vitrectomy for Endophthalmitis and Eye Infections. Completed.

Detailed Summary

To determine the role of initial pars plana vitrectomy in the management of postoperative bacterial endophthalmitis. To determine the role of intravenous antibiotics in the management of bacterial endophthalmitis. To determine which factors, other than treatment, predict outcome in postoperative bacterial endophthalmitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEndophthalmitis, Eye Infections
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
19901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 24, 1999
Enrollment StartFeb 1, 1990
Study CompletionJan 1, 1995
TodayJul 2, 2026
Posted 26.8 years ago

Interventions

Intravitreal Antibioticsdrug

Initial Pars Plana Vitrectomyprocedure